دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Review of robot-assisted laparoscopic surgery in management of infant congenital urology: Advances and limitations in utilization and learning
Alyssa M. Lombardo, Mohan S. Gundeti
doi : 10.1111/iju.15105
As robotic-assisted (RAL) surgery expanded to treat pediatric congenital disease, infant anatomy and physiology posed unique challenges that prompted adaptations to the technology and surgical technique, which are compiled and reviewed in this manuscript.
Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study
Wei Chen, Minato Yokoyama, Masaki Kobayashi, Bo Fan, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Masumi Ai, Kiyohide Fushimi, Norio Nonomura, Yasuhisa Fujii
doi : 10.1111/iju.15099
To clarify the trends in radical cystectomy and to compare surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy based on a Japanese nationwide database.
Transurethral lidocaine (100 mg) bladder irrigation (TULI100) reduces the incidence of catheter related bladder discomfort in transurethral resection of bladder tumors: A randomized, double blind, controlled trial
Ajay Singh, Choro Athiphro Kayina, Naveen Naik, Venkata Ganesh, Sumit Kumar, Vijayant Kumar Pandey, Girdhar S. Bora, Kulbhushan Saini, Shiv Lal Soni, Narender Kaloria, Tanvir Samra, Vikas Saini
doi : 10.1111/iju.15100
Transurethral resection of bladder tumors (TURBT) surgeries requires post-resection catheterization for continuous irrigation of the bladder. This indwelling catheter is associated with distressing catheter-related bladder discomfort (CRBD) and increases postoperative pain and agitation.
Editorial Comment on Transurethral lidocaine (100 mg) bladder irrigation (TULI100) reduces the incidence of catheter-related bladder discomfort in TURBT: A randomized, double-blind, controlled trial
Ahmed M. Moeen MD
doi : 10.1111/iju.15131
Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results-Medicare datac
Naomi B. Haas, Yan Song, Jaqueline Willemann Rogerio, Su Zhang, Christopher Carley, JingJing Zhu, Rituparna Bhattacharya, James Signorovitch, Murali Sundaram
doi : 10.1111/iju.15104
This study aimed to assess whether disease-free survival (DFS) may serve as a predictor for long-term survival among patients with intermediate-high risk or high risk renal cell carcinoma (RCC) post-nephrectomy when overall survival (OS) is unavailable.
Editorial Comment on Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results-Medicare data
Hiroki Ishihara MD, PhD, Toshio Takagi MD, PhD
doi : 10.1111/iju.15129
Comparison of robot-assisted partial nephrectomy with soft coagulation and double-layer technique for complex and non-complex tumors
Keito Shiozaki, Kazuyoshi Izumi, Yutaro Sasaki, Yoshito Kusuhara, Tomoya Fukawa, Yasuyo Yamamoto, Kunihisa Yamaguchi, Hirofumi Izaki, Masayuki Takahashi, Yasuo Kawanishi, Hiroomi Kanayama
doi : 10.1111/iju.15112
To compare the postoperative outcomes of robot-assisted partial nephrectomy when only the inner layer is sutured (single-layer technique with soft coagulation) with those when sutures are placed in the inner and outer layers (double-layer technique) in patients with and without complex renal tumors.
A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer
Takuma Kato, Yoichiro Tohi, Tomoko Honda, Iori Matsuda, Yu Osaki, Hirohito Naito, Yuki Matsuoka, Homare Okazoe, Rikiya Taoka, Hiroyuki Tsunemori, Nobufumi Ueda, Mikio Sugimoto
doi : 10.1111/iju.15102
To conduct a national questionnaire survey of Japanese urologists on active surveillance (AS) for low- and intermediate-risk prostate cancer (PCa).
Editorial Comment to “A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer�
Ryuji Matsumoto MD, PhD
doi : 10.1111/iju.15127
Editorial Comment on a national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer
Takeshi Kishida M.D.
doi : 10.1111/iju.15142
C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysis
Ryoma Nishikawa, Makito Miyake, Shuichi Morizane, Ryutaro Shimizu, Shogo Teraoka, Masashi Honda, Kota Iida, Nobutaka Nishimura, Tomokazu Sazuka, Takahiro Kimura, Akihiro Ito, Kenichiro Shiga, Rikiya Taoka, Takahiro Kojima, Takashi Kobayashi, Naotaka Nishiyama, Hiroshi Kitamura, Hiroyuki Nishiyama, Kiyohide Fujimoto, Atsushi Takenaka
doi : 10.1111/iju.15106
To investigate the involvement of pretreatment C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR) in the prognosis of patients who underwent intravesical bacillus Calmette-Guérin (BCG) therapy for non-muscle invasive bladder cancer (NMIBC).
External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study
Ali Abdel Raheem, Isotta Landi, Ibrahim Alowidah, Umberto Capitanio, Francesco Montorsi, Alessandro Larcher, Ithaar Derweesh, Fady Ghali, Alexander Mottrie, Elio Mazzone, Geert De Naeyer, Riccardo Campi, Francesco Sessa, Marco Carini, Andrea Minervini, Jay D. Raman, Chris J. Rjepaj, Maximilian C. Kriegmair, Riccardo Autorino, Alessandro Veccia, Maria Carmen Mir, Francesco Claps, Young Deuk Choi, Won Sik Ham, Glen Denmer Santok, John Paul Tadifa, Justin Syling, Maria Furlan, Claudio Simeone, Maida Bada, Antonio Celia, Diego M. Carrión, Alfredo Aguilera Bazan, Cristina Ballesteros Ruiz, Manar Malki, Neil Barber, Muddassar Hussain, Salvatore Micali, Stefano Puliatti, Ahmed Ghaith, Ayman Hagras, Ayman M. Ghoneem, Ahmed Eissa, Abdulrahman Alqahtani, Abdullah Rumaih, Abdelaziz Alwahabi, Mohammed Jayed Alenzi, Nicola Pavan, Fabio Traunero, Alessandro Antonelli, Antonio Benito Porcaro, Ester Illiano, Elisabetta Costantini, Koon Ho Rha
doi : 10.1111/iju.15108
From 2000 through 2018, 3526 consecutive patients underwent on-clamp PN for cT1 renal masses at 23 centers were included. All patients had two kidneys, preoperative eGFR ≥60 ml/min/1.73 m2, and a minimum follow-up of 12 months
Editorial Comment to External validation of Yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study
Tsunenori Kondo M.D., Ph.D.
doi : 10.1111/iju.15125
Editorial Comment on External validation of Yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study
Riccardo Bertolo M.D., Ph.D.
doi : 10.1111/iju.15145
Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors
Kenshiro Takemoto, Yohei Sekino, Hiroyuki Kitano, Kenichiro Ikeda, Keisuke Goto, Keisuke Hieda, Tetsutaro Hayashi, Yasuhisa Hasegawa, Masao Kato, Yuichi Kadonishi, Mitsuru Kajiwara, Jun Teishima, Koji Mita, Satoshi Maruyama, Masanobu Shigeta, Nobuyuki Hinata
doi : 10.1111/iju.15110
To evaluate the significance of both low and high body mass index (BMI) as a biomarker in first-line tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC).
Chemotherapy with gemcitabine and cisplatin downregulates tumor expression level of nectin-4 in a syngeneic model of murine MBT2 urothelial cancer cell line and C3H mice
Makito Miyake MD, Yuki Oda MD, Nobutaka Nishimura MD, Takuto Shimizu MD, Tomomi Fujii MD, Kiyohide Fujimoto MD
doi : 10.1111/iju.15109
Evaluation of trends in prescription drugs for overactive bladder in Japanese patients
Motofumi Suzuki MD, PhD, Masahiro Yamamoto MD, Taichi Shiratori MD, Akihiro Naito MD, PhD, Masaki Nakamura MD, PhD
doi : 10.1111/iju.15117
Letter to the Editor Re: Robot-assisted versus conventional laparoscopic partial nephrectomy for renal hilar tumors: Parenchymal preservation and functional recovery
Collin Elijah Rui Hung Ho MBBS, Wei Zheng So MBBS, Ho Yee Tiong MBBS, FAMS
doi : 10.1111/iju.15115
